BLNK is an adaptor protein of the B-cell receptor signaling pathway and has been identified as an independent risk factor for colorectal cancer recurrence as well as a positive regulator of Met signaling in non-small cell lung cancer [66, 67]. The gene discussed is MET; the disease is non-small cell lung carcinoma.